IBOV 166,191.45 ▼ 0.82% IPC MEX 71,033.20 ▲ 0.30% MERVAL 2,848,945 — — USD/BRL5.49▲ 0.51% USD/MXN18.73▲ 0.59% USD/CLP977.69▲ 1.16% USD/COP3,230▼ 0.63% USD/PEN3.44▼ 0.08% USD/ARS1,545▼ 0.19% USD/UYU40.22▲ 3.24% USD/PYG6,358▲ 9.88% USD/BOB11.92▲ 1.74% USD/DOP59.79▼ 1.17% USD/CRC449.63▲ 2.27% USD/GTQ7.64▲ 3.16% USD/HNL26.87▼ 0.09% USD/NIO36.62▲ 0.07% USD/VES892.65▼ 0.13% USD/PAB1.00— 0.00% USD/BZD2.00— 0.00% USD/JMD157.79▲ 2.67% USD/TTD6.64▲ 1.14% EUR/BRL6.17▲ 0.44% BRENT 98.96 ▲ 4.59% WTI 91.00 ▲ 3.27% IRON ORE 161.91 — — COPPER 6.24 ▼ 2.48% GOLD 4,106 ▲ 0.82% SILVER 52.10 ▼ 0.04% SOY 1,190 ▼ 0.29% CORN 440.75 ▼ 0.79% WHEAT 599.25 ▲ 0.13% COFFEE 277.40 ▼ 0.84% SUGAR 18.60 ▲ 0.70% ORANGE JUICE 136.15 ▲ 3.54% COTTON 78.45 ▲ 0.44% COCOA 5,290 ▼ 3.04% BEEF 214.48 ▼ 1.62% CATTLE 320.58 ▼ 3.45% LITHIUM 60.18 ▲ 0.13% PETR4 45.95 ▼ 2.48% VALE3 62.67 ▲ 0.51% ITUB4 39.97 ▲ 0.65% BBDC4 13.77 ▼ 2.06% ABEV3 15.48 ▲ 1.51% BBAS3 16.49 — 0.00% B3SA3 14.36 ▲ 0.42% WEGE3 48.30 ▼ 3.50% PRIO3 61.54 ▼ 0.97% SUZB3 52.29 ▼ 0.11% RENT3 29.07 ▼ 1.32% AZZA3 14.06 ▲ 0.64% CSAN3 2.50 ▲ 4.60% RAIZ4 27.57 ▲ 1.73% PCAR3 2.39 ▲ 3.91% GMAT3 3.71 ▲ 5.10% PSSA3 43.71 ▼ 2.63% CVCB3 0.82 ▲ 1.23% POSI3 3.11 ▼ 1.89% SLCE3 16.35 ▼ 1.51% NATU3 5.35 ▼ 1.29% BRKM5 3.03 ▼ 0.66% RANI3 8.46 ▼ 1.97% CSNA3 4.05 ▼ 0.74% IBOV 166,191.45 ▼ 0.82% IPC MEX 71,033.20 ▲ 0.30% MERVAL 2,848,945 — — USD/BRL 5.49 ▲ 0.51% USD/MXN 18.74 ▲ 0.65% USD/CLP 977.69 ▲ 1.16% USD/COP 3,230 ▼ 0.63% USD/PEN 3.44 ▼ 0.08% USD/ARS 1,545 ▼ 0.19% USD/UYU 40.22 ▲ 3.24% USD/PYG 6,358 ▲ 9.88% USD/BOB 11.92 ▲ 1.74% USD/DOP 59.79 ▼ 1.17% USD/CRC 449.63 ▲ 2.27% USD/GTQ 7.64 ▲ 3.16% USD/HNL 26.87 ▼ 0.09% USD/NIO 36.62 ▲ 0.07% USD/VES 892.65 ▼ 0.13% USD/PAB 1.00 — 0.00% USD/BZD 2.00 — 0.00% USD/JMD 157.79 ▲ 2.67% USD/TTD 6.64 ▲ 1.14% EUR/BRL 6.17 ▲ 0.44% BRENT 98.96 ▲ 4.59% WTI 91.00 ▲ 3.27% IRON ORE 161.91 — — COPPER 6.24 ▼ 2.48% GOLD 4,106 ▲ 0.82% SILVER 52.10 ▼ 0.04% SOY 1,190 ▼ 0.29% CORN 440.75 ▼ 0.79% WHEAT 599.25 ▲ 0.13% COFFEE 277.40 ▼ 0.84% SUGAR 18.60 ▲ 0.70% ORANGE JUICE 136.15 ▲ 3.54% COTTON 78.45 ▲ 0.44% COCOA 5,290 ▼ 3.04% BEEF 214.48 ▼ 1.62% CATTLE 320.58 ▼ 3.45% LITHIUM 60.18 ▲ 0.13% PETR4 45.95 ▼ 2.48% VALE3 62.67 ▲ 0.51% ITUB4 39.97 ▲ 0.65% BBDC4 13.77 ▼ 2.06% ABEV3 15.48 ▲ 1.51% BBAS3 16.49 — 0.00% B3SA3 14.36 ▲ 0.42% WEGE3 48.30 ▼ 3.50% PRIO3 61.54 ▼ 0.97% SUZB3 52.29 ▼ 0.11% RENT3 29.07 ▼ 1.32% AZZA3 14.06 ▲ 0.64% CSAN3 2.50 ▲ 4.60% RAIZ4 27.57 ▲ 1.73% PCAR3 2.39 ▲ 3.91% GMAT3 3.71 ▲ 5.10% PSSA3 43.71 ▼ 2.63% CVCB3 0.82 ▲ 1.23% POSI3 3.11 ▼ 1.89% SLCE3 16.35 ▼ 1.51% NATU3 5.35 ▼ 1.29% BRKM5 3.03 ▼ 0.66% RANI3 8.46 ▼ 1.97% CSNA3 4.05 ▼ 0.74%
since 2009
Friday, November 6, 2026

Covid-19 Brazil

Uruguay reports Covid vaccines reduce deaths and ICU admissions by over 90%

By · June 9, 2021 · 2 min read

RIO DE JANEIRO, BRAZIL – Covid-19-related intensive care admissions and deaths have been reduced by over 90% in Uruguay’s general population who have taken both doses of the CoronaVac and Pfizer vaccines, a report released by the government on Tuesday stated.

The country, with a population of 3.5 million, has been conducting a successful vaccination campaign, which places it alongside Chile at the forefront of immunization in South America.

1
Covid vaccine reduces deaths and ICU admissions by over 90%.
RT
Ask Rio Times
This story and the bigger picture.
Open the full Ask Rio Times →

Nevertheless, Uruguayans are experiencing a strong wave of infections, which place the country among the first in the world in number of deaths per million inhabitants.

According to Ministry of Public Health data, almost 52% of the population has been administered one dose of a Covid-19 vaccine and 29% has been immunized with both vaccine doses by June 1. The report’s results include people vaccinated with both doses after more than 14 days after the last one was administered.

With respect to the CoronaVac vaccine, developed by Chinese Sinovac Biotech, the study showed that “in all subgroups analyzed, the percentage of efficacy in reducing incidence of cases exceeds 61%; the reduction in intensive care unit (ICU) admissions is over 92%, and the reduction in deaths from the disease exceeds 95%.”

The CoronaVac subgroups correspond to the population segments aged between 18 and 49 and between 50 and 69.

Concerning the vaccine developed by Pfizer/BioNTech, the document adds that “the percentage of efficacy in reducing incidence of cases exceeds 78%, in reducing ICU admissions exceeds 94%, and in preventing deaths is above 94%.” Pfizer’s immunizer was intended for people aged 80 and older, and for healthcare professionals.

Source: Swissinfo

Editorial responsibility: Matthias Camenzind, Editor-in-Chief · Editorial standards · Report an error

The Rio Times · Power Map
See who really holds power in Latin America
Click to open the Power Map →

Brazil runoff date: Sunday, October 25, poll closing times and when results start · Brazil runoff polls: Flávio 51%, Lula 49% · Kalshi and Polymarket odds

Rotate for Best Experience

This report is optimized for landscape viewing. Rotate your phone for the full experience.